共 14 条
[1]
Ichizawa N(2002)Long-term results of T1a, T1b and T1c Invasive breast carcinomas in Japanese women: validation of the UICC T1 subgroup classification Jpn J Clin Oncol 32 108-109
[2]
Schilling K(2008)The role of positron emission mammography in breast cancer imaging and management Appl Radiol 37 26-36
[3]
Berg WA(2006)High-resolution fluorodeoxyglucose positron emission tomography with compression (“positron emission mammography”) is highly accurate in depicting primary breast cancer Breast J 12 309-323
[4]
Berg WA(2011)Breast cancer: comparative effectiveness of positron emission mammography and MR imaging in presurgical planning for the ipsilateral breast Radiology 258 59-72
[5]
Schilling K(2011)Positron emission mammography in breast cancer presurgical planning: comparisons with magnetic resonance imaging Eur J Nucl Med Mol Imaging 38 23-36
[6]
Iima M(2012)Clinical performance of 2 dedicated PET scanners for breast imaging: initial evaluation J Nucl Med 53 1534-1542
[7]
Narayanan D(2011)Interpretation of positron emission mammography and MRI by experienced breast imaging radiologists: performance and observer reproducibility AJR Am J Roentgenol 196 971-981
[8]
Wahl RL(1993)Metabolic monitoring of breast cancer chemohormonotherapy using positron emission tomography: initial evaluation J Clin Oncol 11 2101-2111
[9]
Smith IC(2000)Positron emission tomography using [(18)F]-fluorodeoxy- J Clin Oncol 18 1676-1688
[10]
Rousseau C(2006)-glucose to predict the pathologic response of breast cancer to primary chemotherapy J Clin Oncol 24 3566-3572